RecallRadar

FDA Drug recall D-0177-2023

0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, Nephron Pharmaceuticals Corporation, 4500 12th St. Extensio…

On 2023-02-01 the FDA classified a Class II recall of 0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, Nephron Pharmaceuticals Corporation, 4500 12th St. Extensio… by Nephron Sc, citing CGMP Deviations: potential for trace amounts of product carryover.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0177-2023
ClassificationClass II
Statusterminated
Initiated2023-01-12
Published2023-02-01
Last updated2026-09-13 11:52 UTC
CompanyNephron Sc
DistributionUS

Product

0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, Nephron Pharmaceuticals Corporation, 4500 12th St. Extension, W. Columbia, SC 29172, NDC: 0487-4301-10, UPC 3 04874 30110 3.

Reason

CGMP Deviations: potential for trace amounts of product carryover.

Identifiers

upc304874301103
ndc0487-4301-25
ndc0487-4301-10
ndc0487-4301-05
ndc0487-4301-50
code_infoLot: 271043, Exp. 03/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0177-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.